Patents by Inventor Marcella Canton

Marcella Canton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS
    Publication number: 20230257342
    Abstract: The present invention relates to novel compounds which are capable of inhibiting semicarbazide-sensitive amine oxidase (SSAO/VAP-1) and monoamine oxidase B (MAO-B). These compounds are useful for treatment of a variety of neuromuscular diseases, such as muscular dystrophies, and neuroinflammatory diseases, including both peripheral and central disorders in human subjects, as well as in pets and livestock. In addition, the present invention relates to pharmaceutical compositions containing these compounds, as well as various uses thereof.
    Type: Application
    Filed: June 25, 2021
    Publication date: August 17, 2023
    Inventors: Alan Duncan Robertson, Alison Dorothy Findlay, Alberto Buson, Craig Ivan Turner, Dieter Wolfgang Hamprecht, Jonathan Stuart Foot, Mandar Deodhar, Wolfgang Jarolimek, Serena Becchi, Bernard Walter Balleine, Marcella Canton, Libero Vitiello, Bert Blaauw
  • NEW USE OF INHIBITORS OF MONOAMINE OXIDASE TYPE B
    Publication number: 20210308078
    Abstract: The invention relates to inhibitors of monoamine oxidase type B (iMAO-B) for use in the treatment of pathologies or disorders associated with inflammasome activation, pharmaceutical compositions comprising said inhibitors for use thereof, medical devices comprising such compositions, and therapeutic methods for treatment of pathologies or disorders associated with inflammasome activation by administration of inhibitors of the monoamine oxidase type B enzyme.
    Type: Application
    Filed: June 18, 2019
    Publication date: October 7, 2021
    Inventors: Antonella VIOLA, Marcella CANTON
  • Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
    Patent number: 9694014
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: July 4, 2017
    Assignee: Universita Degli Studi di Padova
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • TREATMENT OF MUSCULAR DYSTROPHIES AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS
    Publication number: 20150290201
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Application
    Filed: July 15, 2013
    Publication date: October 15, 2015
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
    Patent number: 8487008
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Grant
    Filed: June 22, 2011
    Date of Patent: July 16, 2013
    Assignee: Universita degli Studi di Padova
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza
  • TREATMENT OF MUSCULAR DYSTROPHIES AND ASSOCIATED CONDITIONS BY ADMINISTRATION OF MONOAMINE OXIDASE INHIBITORS
    Publication number: 20120329800
    Abstract: Administration of a monoamine oxidase inhibitor is useful in the prevention and treatment of muscle dystrophy. Methods and compositions for inhibiting the production of reactive oxygen species in a muscle cell overproducing reactive oxygen species are provided herein.
    Type: Application
    Filed: June 22, 2011
    Publication date: December 27, 2012
    Inventors: Paolo Bonaldo, Marcella Canton, Fabio DiLisa, Sara Menazza